NCT07017504

Brief Summary

This study investigates the effects of a proprioception-enhancing assistive orthosis on balance and joint sense in geriatric patients with age-related diseases. The study uses wearable devices that deliver vibration stimuli to improve proprioceptive feedback. A total of 20 participants will be enrolled in a 24-month, IRB-approved trial at Seoul National University Hospital. The study assesses functional balance and joint position sense before and after using the device.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Jul 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jul 2025Jul 2027

First Submitted

Initial submission to the registry

May 30, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

June 12, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 30, 2025

Last Update Submit

June 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postural Sway

    This measures the amount of body sway during quiet standing (static) or controlled leaning in various directions (dynamic). Parameters such as center of pressure (COP) displacement, velocity, and area are recorded to assess balance stability. Assessments will be conducted under the following three conditions: 1. without the orthosis, 2. with the orthosis worn but vibration inactive, and 3. with the orthosis worn and vibration active.

    up to 2 weeks

Secondary Outcomes (5)

  • Berg Balance Scale

    up to 2 weeks

  • Romberg Test

    up to 2 weeks

  • Passive Joint Position Reproduction Test (Passive JPR)

    up to 4 weeks

  • Active Joint Position Reproduction Test (Active JPR)

    up to 4 weeks

  • Threshold to Detection of Passive Motion (TTDPM)

    up to 4 weeks

Study Arms (1)

Proprioception-Enhancing Orthosis

EXPERIMENTAL

Geriatric patients with age-related diseases will undergo three assessment phases: (1) without the orthosis, (2) with the orthosis worn but vibration inactive, and (3) with the orthosis worn and vibration active.

Device: proprioception-enhancing assistive orthosis

Interventions

A wearable device that provides mechanical vibration to the tendons around the knee and ankle to enhance proprioceptive feedback. Vibration intensity and timing are controlled automatically based on body tilt measured by an IMU sensor. The device is applied during balance and joint sense assessments conducted across three visits.

Proprioception-Enhancing Orthosis

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients with age-related diseases affecting balance and joint sense, who meet two or more of the following criteria for sarcopenia:
  • Muscle strength: Handgrip strength \< 28 kg (men), \< 18 kg (women)
  • Physical performance: Short Physical Performance Battery (SPPB) ≤ 8 points
  • Muscle mass: Bioimpedance analysis showing \< 7.0 kg/m² (men), \< 5.7 kg/m² (women)
  • Able to fully understand and follow instructions related to walking, sitting, and balance.

You may not qualify if:

  • Unable or unwilling to provide informed consent
  • High risk of falls due to severe visual impairment or dizziness
  • Communication difficulties due to speech, language, or hearing problems
  • Inability to walk independently without assistive devices
  • History of diseases affecting gait, efficiency, or endurance, such as:
  • Neurological disorders (e.g., stroke, Parkinson's disease)
  • Musculoskeletal disorders affecting the lower limbs
  • History of major orthopedic surgery on the lower limbs
  • Severe back pain or musculoskeletal pain affecting gait
  • Cardiovascular disease including heart failure or uncontrolled hypertension
  • Pulmonary diseases requiring regular oxygen therapy
  • Cancer requiring treatment within the past 3 years (except for non-melanoma skin cancer or early-stage breast/prostate cancer)
  • Psychiatric disorders such as schizophrenia, other psychoses, or bipolar disorder
  • Any other disease that significantly limits mobility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, Jongno, South Korea

Location

Central Study Contacts

JungHyun Kim, prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2025

First Posted

June 12, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

June 12, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations